Literature DB >> 7698580

Accumulation and cellular localization of fibrinogen/fibrin during short-term and long-term rat liver injury.

K Neubauer1, T Knittel, T Armbrust, G Ramadori.   

Abstract

BACKGROUND/AIMS: During liver fibrosis, there is a putative pacemaker role of fibronectin. Fibrinogen is closely linked to fibronectin during clotting processes. The aim of this study was to show fibrinogen gene expression during liver damage.
METHODS: Fibrinogen/fibrin deposition in damaged livers was studied by immunohistology. Fibrinogen gene expression was analyzed in vivo in a model of CCl4-induced rat liver damage and in vitro in isolated liver cells by means of Northern blot analysis and in situ hybridization.
RESULTS: Immunohistology showed striking amounts of fibrinogen and fibrin deposits in pericentral necrotic areas (short-term damage) and within fibrotic septa (long-term damage). Total RNA extracted from short-term-damaged livers contained an increased fibrinogen messenger RNA level. By in situ hybridization, fibrinogen transcripts were localized in cells of the nonnecrotic areas (short-term damage) and outside fibrotic septa (long-term damage). In vitro studies showed fibrinogen de novo synthesis restricted to hepatocytes.
CONCLUSIONS: The results show fibrinogen/fibrin deposition during short-term liver injury and liver fibrogenesis, which may suggest the involvement of a "clotting-like process" in short-term liver damage and liver fibrosis. The data might indicate that fibrin/fibronectin constitute a "provisional matrix," which affects the attraction and proliferation of inflammatory and matrix-producing cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7698580     DOI: 10.1016/0016-5085(95)90211-2

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  48 in total

Review 1.  Autoantibodies as prognostic markers in autoimmune liver disease.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-05-13       Impact factor: 3.199

2.  Severe fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-1) complex.

Authors:  K S Brown; M J Keogh; N Tagiuri; M J Grainge; J S Presanis; S D Ryder; W L Irving; J K Ball; R B Sim; T P Hickling
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

Review 3.  Advances in functional and molecular MRI technologies in chronic liver diseases.

Authors:  Iris Y Zhou; Onofrio A Catalano; Peter Caravan
Journal:  J Hepatol       Date:  2020-06-22       Impact factor: 25.083

4.  Fibrin deposition following bile duct injury limits fibrosis through an αMβ2-dependent mechanism.

Authors:  Nikita Joshi; Anna K Kopec; Jessica L Ray; Holly Cline-Fedewa; Atta Nawabi; Timothy Schmitt; Rance Nault; Timothy R Zacharewski; Cheryl E Rockwell; Matthew J Flick; James P Luyendyk
Journal:  Blood       Date:  2016-02-26       Impact factor: 22.113

5.  Plasminogen activators direct reorganization of the liver lobule after acute injury.

Authors:  J A Bezerra; A R Currier; H Melin-Aldana; G Sabla; T H Bugge; K W Kombrinck; J L Degen
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

6.  Chronic passive venous congestion drives hepatic fibrogenesis via sinusoidal thrombosis and mechanical forces.

Authors:  Douglas A Simonetto; Hui-yin Yang; Meng Yin; Thiago M de Assuncao; Jung Hee Kwon; Moira Hilscher; Shuchong Pan; Liu Yang; Yan Bi; Arthur Beyder; Sheng Cao; Robert D Simari; Richard Ehman; Patrick S Kamath; Vijay H Shah
Journal:  Hepatology       Date:  2015-01-05       Impact factor: 17.425

Review 7.  Molecular imaging of fibrosis: recent advances and future directions.

Authors:  Sydney B Montesi; Pauline Désogère; Bryan C Fuchs; Peter Caravan
Journal:  J Clin Invest       Date:  2019-01-02       Impact factor: 14.808

8.  Antifibrotic effect of heparin on liver fibrosis model in rats.

Authors:  Binita Shah; Gaurang Shah
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-12-06

9.  Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection.

Authors:  M Wright; R Goldin; S Hellier; S Knapp; A Frodsham; B Hennig; A Hill; R Apple; S Cheng; H Thomas; M Thursz
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

10.  Expression of ECM proteins fibulin-1 and -2 in acute and chronic liver disease and in cultured rat liver cells.

Authors:  Fabio Piscaglia; József Dudás; Thomas Knittel; Paola Di Rocco; Dominik Kobold; Bernhard Saile; Maria Assunta Zocco; Rupert Timpl; Giuliano Ramadori
Journal:  Cell Tissue Res       Date:  2009-07-17       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.